Key result
Pregnancy-associated MI demands tailored diagnosis and management to reduce maternal cardiovascular morbidity.
Why the study?
Pregnancy-associated myocardial infarction is a primary contributor to maternal cardiovascular morbidity and mortality, requiring specific attention to etiology, diagnostic evaluation, treatment, and postevent care.
This review summarizes current knowledge, consensus statements, and essential nuances regarding the diagnosis, treatment, and post-event care of pregnancy-associated myocardial infarction.
Answers are grounded in this paper and cite their sources.
May inform specialized peripartum MI protocols; leaves open the need for prospective validation.
Pregnancy-associated myocardial infarction is a primary contributor to maternal cardiovascular morbidity and mortality. Specific attention to the cause of myocardial infarction, diagnostic evaluation, treatment strategies, and postevent care is necessary when treating women with pregnancy-associated myocardial infarction. This review summarizes the current knowledge, consensus statements, and essential nuances.
No takes yet. Share an insight, caveat, or question.
Tweet et al. (2020) conducted a review in Pregnancy-associated myocardial infarction. Pregnancy-associated myocardial infarction requires specific attention to its causes, diagnostic evaluation, treatment strategies, and postevent care to reduce maternal cardiovascular morbidity.
Synapse has enriched 10 related papers. Consider them for comparative context: